摘要:
Disclosed herein is a method for manufacturing a composition promoting bone density enhancement, the method including preparing a mixture of Angelica gigas, Cnidium officinale, Phlomis umbrosa, Astragalus membranceus, Amomi fructus, Citri unshius pericarpium, Drynariae rhizoma, Codonopsis pilosulae radix, frankincense, and myrrh, aging the mixture, drying the mixture and grinding the dried mixture into a powder, and extracting a liquid from the powder.
摘要:
This application relates to the treatment of lysosomal storage disorders resulting from a deficiency of acid maltase and/or acid α-glucosidase by administering active barley in comminuted form. Also disclosed are methods of replacing acid maltase and/or acid α-glucosidase by administering active barley in comminuted form. Further disclosed are compositions for carrying out these methods.
摘要:
The present invention is directed to pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of an array of the manifestations of metabolic syndromes, including Type 2 diabetes, hyperlipidemia, weight gain, obesity, insulin resistance, hypertension, atherosclerosis, fatty liver diseases and certain chronic inflammatory states that lead to these manifestations, among others. In additional aspects, the present invention relates to compositions and methods which may be used to treat, inhibit or reduce the likelihood of hepatitis viral infections, including Hepatitis B and Hepatitis C viral infections, as well as the secondary disease states and/or conditions which are often associated with such viral infections, including hepatic steatosis (steatohepatitis), cirrhosis, fatty liver and hepatocellular cancer, among other disease states or conditions.
摘要:
The present invention is directed to pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of an array of the manifestations of metabolic syndromes, including Type 2 diabetes, hyperlipidemia, weight gain, obesity, insulin resistance, hypertension, atherosclerosis, fatty liver diseases and certain chronic inflammatory states that lead to these manifestations, among others. In additional aspects, the present invention relates to compositions and methods which may be used to treat, inhibit or reduce the likelihood of hepatitis viral infections, including Hepatitis B and Hepatitis C viral infections, as well as the secondary disease states and/or conditions which are often associated with such viral infections, including hepatic steatosis (steatohepatitis), cirrhosis, fatty liver and hepatocellular cancer, among other disease states or conditions.
摘要:
The present invention relates to an herbal tea without excipient used as milk supplement. The herbal tea comprises the following medicinal materials: Raw Semen Coicis, Herba Lophatheri, Setaria Italica, Prepared Semen Coicis, Fructus Hordei Germinatus, Fructus Setariae Germinatus, Medulla Junci and Triticum Aestivum, wherein the Triticum Aestivum is used as a forming agent in the herbal tea. The method of preparing the herbal tea comprises the following steps: (a) weighing the medicinal materials according to the formula of herbal tea; (b) mixing the medicinal materials except for Triticum Aestivum together, decocting the resulting mixture with water 1-3 time(s), each time lasting for 0.5-2 hours, then combining the decoctions obtained from each time, filtering, and concentrating the resulting filtrate into a concentrated solution with relative density of 1.0-1.3 g/cm3; (c) pulverizing the weighed Triticum Aestivum into particles of 15-40 mesh size, then dispersing the concentrated solution obtained from the step (b) to the pulverized particles of Triticum Aestivum; (d) fully drying the pulverized particles of Triticum Aestivum loaded with the concentrated solution obtained from the step (c), then packing the particles in a desired product form. The herbal tea of the present invention is specially suitable for babies who have trouble with intestine heat and stomach heat resulted from their long-term intake of milk product, since long-term intake of undesired components such as sucrose or other excipients which are not beneficial for their health is avoided.
摘要:
The present invention is directed to bioactive botanical cosmetic compositions derived from membrane and cell serum fractions of plant cell juice. The present invention also relates to the methods for preparing these bioactive botanical cosmetic compositions and the uses of these compositions in various cosmetic formulations and as topical skin cosmetic applications.
摘要:
Disclosed are nutritional compositions comprising a synergistic combination of cereal beta-glucans, including oat and or barley beta-glucans and Salacia extract, including Salacia oblonga, that are particularly useful in controlling the blood glucose response in a diabetic or other appropriate individual. The nutritional compositions are especially useful when formulated in powder form and then reconstituted with an appropriate liquid or sprinkled onto food during a meal, to thus control the postprandial blood glucose response to that meal.
摘要:
The present invention relates to oral compositions comprising a β (1-3) β (1-4) glucan and one, or more than one compound of interest. In particular, the present invention provides an oral composition comprising an effective amount of a β (1-3) β (1-4) glucan and an effective amount of one, or more than one of an antibacterial agent, a botanical extract, and a flavouring agent, and also provides a method of using this composition for maintaining fresh breath in a subject over a prolonged period of time.
摘要:
It is an object of the invention to provide a composition with an excellent action of inhibiting vascularization, as prepared by a simple method suitable for actual production from an inexpensive, relatively readily available material without any problematic safety profile at an industrial scale without any complicated purification step. The composition is a composition for inhibiting vascularization, which contains a barley-derived ingredient selected from the group consisting of an unpolished barley ethyl alcohol extract fraction, an unpolished barley alkali extract fraction and fermented barley (preferably, a residual solution from the distillation of barley distilled spirits) as the active component with an action of inhibiting vascularization. The composition for inhibiting vascularization is a composition for therapeutically treating or preventing diseases which vascularization should be inhibited, specifically diseases with an etiology of abnormal vascularization in tumor or cancer, chronic inflammation or retinopathy. The composition is in a form selected from the group consisting of food additives, food materials, foods and drinks, pharmaceutical products under regulations by the Ministry of Health and Labor in Japan and quasi-pharmaceutical products under regulations by the Ministry of Health and Labor in Japan, and feeds.
摘要:
A reduction inhibitory agent for active-oxygen eliminating activity comprises trehalose as an effective ingredient. A method for inhibiting the reduction of active-oxygen eliminating activity comprises incorporating either trehalose or the reduction inhibitory agent into plant edible products and/or plant antioxidants. A composition is provided that reduces the active-oxygen eliminating activity of plant edible products and/or plant antioxidants.